AKTS insider trading
Open-market stock trades by Aktis Oncology (AKTS) executives and directors: who bought or sold, how many shares, at what price and when.
AKTS insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Czibere Akos | Chief Medical Officer | Sell | 5,099 | $20.19 | $102.97K |
| Sep 23, 2026 | Czibere Akos | Chief Medical Officer | Sell | 7,401 | $21.03 | $155.65K |
| Jul 20, 2026 | Herrmann Ken | director | Sell | 3,506 | $24.56 | $86.12K |
| Jul 20, 2026 | Herrmann Ken | director | Sell | 1,350 | $24.56 | $33.16K |
| Jul 17, 2026 | Herrmann Ken | director | Sell | 3,065 | $25.21 | $77.26K |
| Jul 8, 2026 | Ron-Bigger Shulamit | Chief Operating Officer | Sell | 15,800 | $27.13 | $428.68K |
| Jul 8, 2026 | Ron-Bigger Shulamit | Chief Operating Officer | Sell | 30,000 | $27.94 | $838.14K |
| Jul 8, 2026 | Ron-Bigger Shulamit | Chief Operating Officer | Sell | 4,200 | $28.75 | $120.74K |
| Jul 8, 2026 | Czibere Akos | Chief Medical Officer | Sell | 14,800 | $27.13 | $401.48K |
| Jul 8, 2026 | Czibere Akos | Chief Medical Officer | Sell | 30,829 | $27.95 | $861.74K |
| Jul 8, 2026 | Czibere Akos | Chief Medical Officer | Sell | 4,371 | $28.71 | $125.48K |
- AKTS insiders bought $0.00 and sold $3.23M in open-market trades over their last 11 filings.
Updated 2026-11-03 11:33 UTC